Abstract Peptide surfactants developed in the Centre for Biomolecular Engineering at The University of Queensland are engineered to combine the advantages of traditional surfactants with biodegradability, biocompatibility, formation of a mechanically strong interfacial cohesive network, and reversible stimuli-responsiveness. In this project, the potential of peptide-stabilised emulsions as delivery systems for small interfering RNA (siRNA) was explored. In recent years, the potential of siRNA as a new class of therapeutics has attracted great attention. The ubiquitous nature of RNA interference (RNAi) implies that siRNA can be used to silence any disease-causing gene to treat any disease. The hurdle that needs to be overcome to turn siRNA therapy into clinical reality is its delivery into the cytosol, where gene silencing by siRNA occurs. Although numerous systems have been developed for the delivery of siRNA, safety and efficiency are major concerns associated with current formulations. Therefore this project aimed to prepare a stable peptide emulsion formulation and to conduct initial tests of its ability to deliver siRNA in vitro. The human tumour suppressor gene p53 and the human breast cancer MCF-7 cell line were used as the model gene and model cell line, respectively. The commercially available lipid-based transfection reagent Lipofectamine™ 2000 was used as the benchmark control. Sonication and membrane extrusion were used to formulate emulsions with droplet size (d=120 nm) suitable for intravenous applications using peptide surfactant in the presence of Zn(II). Although these peptide emulsions are stable by themselves and in bovine serum, emulsion stability was found to be strongly affected by the presence of salt, EDTA, and proteins. The instability of AM1 emulsion in cell culture media has been a concern when it was subjected to in vitro cell culture tests. AM1-stabilised emulsion droplets were shown to be taken up by MCF-7 cells. However, siRNA when coupled with AM1 emulsion was not delivered into cells. Cytotoxicity studies showed that peptide surfactants did not exhibit high-level toxicity to CHO cells at the tested concentrations (0.25-2 mg mL-1). AM1 peptide-stabilised emulsions were mildly toxic to CHO cells but no toxicity was observed with MCF-7 cells. Future work could include evaluation of peptide emulsion-siRNA complex formation, and exploring the effects of different cell culture media compositions on emulsion stability and their relation to cytotoxicity.
| Identifer | oai:union.ndltd.org:ADTP/279396 |
| Creators | Kaiyin Hu |
| Source Sets | Australiasian Digital Theses Program |
| Detected Language | English |
Page generated in 0.0017 seconds